Piloting an Insomnia Treatment in Patients With Ulcerative Colitis
Sponsor: Dartmouth-Hitchcock Medical Center
Trial Details
| Condition | Insomnia, Ulcerative Colitis |
| Intervention | CBT-I UC |
| Phase | NA |
| Status | Recruiting |
| Participants | 20 |
| Est. Completion | 1 July 2026 |
| Last Updated | 5 May 2026 |
Primary Outcome
Retention; Recruitment rate; Acceptability; Treatment acceptability questionnaire score
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Active UC based on PRUCSI * Insomnia Severity Index score \> 8 and SOL or WASO \> 30 minutes * Stability of sleep \& UC meds for \> 3 months * Access to internet or cell phone service sufficient for telehealth Exclusion Criteria: * PHQ-9 depression score \> 15 * GAD-7 anxiety score \> 15 * Unstable major psychiatric condition (e.g., bipolar disorder, psychotic disorder) * Current alcohol or substance abuse * Current opioid use for pain control * Current systemic corticosteroid use * Current pregnancy or nursing * Ileostomy or colostomy * Diagnosis of seizure disorder * Diagnosis of sleep apnea * Diagnosis of restless leg syndrome or positive Cambridge-Hopkins RSLq screen * Night shift, rotating shift work, or frequent travel outside of time zone * Residence in a state where we cannot conduct telehealth visits
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service